WealthCollab’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.43K Hold
950
– – ﹤0.01% 630
2026
Q2
$7.7K Sell
950
-206
-18% -$1.51K ﹤0.01% 631
2026
Q1
$7.39K Hold
1,156
– – ﹤0.01% 610
2025
Q4
$6.88K Hold
1,156
– – ﹤0.01% 646
2025
Q3
$6.14K Hold
1,156
– – ﹤0.01% 636
2025
Q2
$3.97K Buy
1,156
+845
+272% +$2.7K ﹤0.01% 685
2025
Q1
$921 Buy
+311
New +$973 ﹤0.01% 847

Other funds holding PBYI

WealthCollab's PBYI Position: Q3 2026 in Review

WealthCollab held its Puma Biotechnology (PBYI) position steady in Q3 2026 at 950 shares worth $9.43K. The position accounts for ﹤0.01% of the portfolio, ranked #630.

WealthCollab first reported a position in PBYI in Q1 2025 and has held it in 7 quarters since. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • WealthCollab held 950 shares of Puma Biotechnology worth $9.43K as of Q3 2026.
  • WealthCollab left its Puma Biotechnology share count unchanged in Q3 2026.
  • Puma Biotechnology made up ﹤0.01% of WealthCollab's portfolio in Q3 2026, its #630 holding.
  • WealthCollab first reported a position in Puma Biotechnology in Q1 2025 and has held it in 7 quarters since.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on WealthCollab's 13F filing for Q3 2026, filed 12 Nov 2026.